Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia

Eur J Haematol. 2010 Mar;84(3):271-3. doi: 10.1111/j.1600-0609.2009.01367.x. Epub 2009 Oct 29.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Caspofungin
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Echinocandins / administration & dosage
  • Echinocandins / therapeutic use
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / surgery
  • Lipopeptides
  • Male
  • Middle Aged
  • Mycoses / prevention & control*
  • Neutropenia / chemically induced
  • Prospective Studies
  • Pyrimidines / administration & dosage
  • Pyrimidines / therapeutic use*
  • Transplantation Conditioning / adverse effects*
  • Triazoles / administration & dosage
  • Triazoles / therapeutic use*
  • Voriconazole
  • Young Adult

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Pyrimidines
  • Triazoles
  • liposomal amphotericin B
  • Amphotericin B
  • Caspofungin
  • Voriconazole